CATALYST PHARMACEUTICALS INC shareholders Q2 2023

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 246 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

CATALYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 159,791$2,1485.81%
GABLES CAPITAL MANAGEMENT INC. 434,930$5,845,4593.83%
JW Asset Management, LLC 563,392$7,571,9882.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,192,000$110,100,4802.35%
Paradiem, LLC 242,421$3,258,1380.93%
SummerHaven Investment Management, LLC 93,156$1,252,0170.80%
Seaport Global Advisors, LLC 17,349$233,1710.69%
MOODY ALDRICH PARTNERS LLC 262,437$3,527,1530.68%
Capital Impact Advisors, LLC 46,096$619,5300.68%
Yorktown Management & Research Co Inc 40,500$544,3200.58%
Westover Capital Advisors, LLC 102,897$1,382,9360.48%
GLOBEFLEX CAPITAL L P 296,496$3,984,9060.44%
AFFINITY INVESTMENT ADVISORS, LLC 49,430$664,3390.38%
NAVELLIER & ASSOCIATES INC 125,444$1,685,9670.33%
Hillsdale Investment Management Inc. 255,320$3,431,5010.32%
OBERWEIS ASSET MANAGEMENT INC/ 183,400$2,464,8960.30%
EMC Capital Management 28,483$3830.30%
J. Goldman & Co LP 526,702$7,078,8750.26%
Lanham O'Dell & Company, Inc. 21,000$282,2400.26%
JUNCTURE WEALTH STRATEGIES, LLC 39,474$530,5310.25%
External links

This page lists CATALYST PHARMACEUTICALS INC's shareholders in Q2 2023. To view CATALYST PHARMACEUTICALS INC's shareholder history, click here.